Over 100 units deployed—the largest scale in Japan. The latest lift-up treatment available nationwide.
SBC Medical Group Holdings(Nasdaq: SBC) (“SBC Medical”), which provides management support for Shonan Beauty Clinic, has announced the introduction of more than 100 units of the high-performance RF (radiofrequency) device “DENSITY,” developed by Seoul-based global aesthetic medical device manufacturer Jeisys Medical. The rollout is scheduled to be completed across all clinics by the end of September 2025.
With this large-scale implementation, Shonan Beauty Clinic will establish a nationwide system to deliver consistent, cutting-edge lifting treatments to patients across Japan.
In the aesthetic medicine market, demand for “non-surgical treatments with minimal downtime” is rapidly growing. In response, Shonan Beauty Clinic has decided to implement the high-performance RF device “DENSITY” across all of its clinics — the largest rollout of its kind in Japan.
Delivering radiofrequency energy deep into the skin, “DENSITY” stimulates collagen and elastin production, helping to tighten the jawline, create a slimmer facial appearance, and lift delicate areas such as the neck and around the eyes. Its three-dimensional irradiation mode and enhanced cooling system provide both greater comfort and improved results. With this large-scale deployment, Shonan Beauty Clinic is establishing a nationwide system to deliver the latest standard in “non-surgical lifting treatments” at all its clinics (excluding Shonan Beauty Clinic Shinjuku Annex 24 and SBC Skin Lab Shinjuku).
Furthermore, Shonan Beauty Dermatology is preparing to introduce “XERF,” an innovative RF device developed by Cynosure Lutronic (Massachusetts, USA), featuring the world’s first dual-frequency technology (6.78 MHz + 2 MHz) to achieve simultaneous lifting and skin texture improvement. The nationwide rollout of XERF is scheduled for completion by the end of October 2025.
SBC Medical Group will continue to raise the standard of aesthetic medicine in Japan through the proactive introduction of advanced devices. By strengthening partnerships with leading global manufacturers, we aim to deliver safe, reliable, and globally benchmarked aesthetic medicine to patients across the country.
About Jeisys Medical
Headquartered in Seoul, South Korea, Jeisys Medical is a global leader in the development and manufacturing of RF (radiofrequency) and HIFU devices for aesthetic medicine. With a focus on skin rejuvenation and tightening, the company develops advanced device portfolios, including its flagship product “DENSITY,” delivering innovative solutions to medical practices worldwide. The company actively conducts marketing activities and academic presentations globally, expanding its footprint in North America as well as Asia. By 2025, it achieved further expansion of its global network, including product launches in major Indian cities and strengthening its presence in North America through the establishment of a local subsidiary.
Jeisys Medical Official Website: https://www.jeisys.com/eng/
About Cynosure Lutronic
Headquartered in Massachusetts, USA, Cynosure Lutronic is a global company developing and manufacturing aesthetic medical devices utilizing laser and RF technologies. It offers an advanced product portfolio addressing clinical needs, including hair removal, skin rejuvenation, and treatment of vascular lesions (EBD: Energy-Based Devices). The company currently maintains a sales network in over 130 countries. Furthermore, the company is highly regarded for its comprehensive support system for medical institutions, including implementation assistance, training, and promotion, which provides robust support for operational systems after device introduction.
Cynosure Lutronic Official Website: https://www.cynosure.com/
RF technology has evolved significantly, truly making this the era of radiofrequency. Aging changes occur not only in the skin's superficial layers but also in its deeper layers. RF treatment's major appeal lies in its ability to deliver thermal energy to these deeper layers, effectively tightening sagging skin and improving skin texture. We believe providing this treatment—suitable for those seeking natural changes with minimal downtime—with consistent quality nationwide represents a major step in establishing a new standard in aesthetic medicine. By leveraging each facility's strengths, we will deliver the optimal treatment for each and every client.
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.
For more information, visit https://sbc-holdings.com/
Contacts
SBC Medical Group Holdings Incorporated (Asia)
Hikaru Fukui / Head of Investor Relations
E-mail: ir@sbc-holdings.com